- Home
- AMC vs ETON Comparison
AMC vs ETON Comparison
Compare AMC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMC | ETON |
|---|---|---|
| Founded | 1920 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.2M | 510.1M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMC | ETON |
|---|---|---|
| Price | $1.11 | $24.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $2.03 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 24.6M | 416.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,848,900,000.00 | $79,950,000.00 |
| Revenue This Year | $10.60 | $40.90 |
| Revenue Next Year | $4.72 | $47.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.57 | ★ 104.94 |
| 52 Week Low | $0.93 | $11.09 |
| 52 Week High | $4.08 | $25.99 |
Technical Indicators
Market Signals| Indicator | AMC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 72.63 |
| Support Level | N/A | $16.38 |
| Resistance Level | $1.25 | N/A |
| Average True Range (ATR) | 0.07 | 1.44 |
| MACD | 0.02 | 0.32 |
| Stochastic Oscillator | 94.74 | 86.43 |
Price Performance
Historical ComparisonAbout AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.